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Abstract
Background—Although uncertainty has been characterized as a major stressor for children with
cancer, it has not been studied systematically.
Objectives—To describe the development and initial psychometric evaluation of a measure of
uncertainty in school-aged children and adolescents with cancer.
Methods—Interview data from the first author’s qualitative study of uncertainty in children
undergoing cancer treatment were used to generate 22 items for the Uncertainty Scale for Kids (USK),
which were evaluated for content validity by expert panels of children with cancer and experienced
clinicians (Stewart, Lynn, & Mishel, 2005). Reliability and validity were evaluated in a sample of
72 children aged 8 to 17 years undergoing cancer treatment.
Results—The USK items underwent minor revision following input from content validity experts
and all 22 were retained for testing. The USK demonstrated strong reliability (Cronbach’s alpha = .
94, test-retest r = .64, p = .005) and preliminary evidence for validity was supported by significant
associations between USK scores and cancer knowledge, complexity of treatment, and anxiety and
depression. Exploratory factor analysis yielded 2 factors, not knowing how serious the illness is and
not knowing what will happen when, which explained 50.4% of the variance.
Discussion—The USK, developed from the perspective of children, performed well in the initial
application, demonstrating strong reliability and preliminary evidence for construct and discriminant
validity. It holds considerable promise for moving the research forward on uncertainty in childhood
cancer.
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Childhood cancer’s evolution from a uniformly fatal condition to a life-threatening but
potentially curable illness has contributed to a paradoxical context of increased optimism
accompanied by pervasive uncertainty (Stewart, 2003). Uncertainty stems not only from the
unknown outcome for any individual child, but also from such factors as an unpredictable
illness trajectory; varying intensity and timing of toxicities and recovery; ambiguous




Nurs Res. Author manuscript; available in PMC 2011 March 1.
Published in final edited form as:













symptoms; and concerns about the long-term impact of cancer and treatment on children’s
social, cognitive, and emotional competence. Although uncertainty has been characterized as
a major stressor both during and following childhood cancer treatment, the impact of
uncertainty on children’s and adolescents’ adjustment to cancer has not been studied
systematically.
Most of the studies identifying uncertainty as an important aspect of childhood cancer and
treatment have been retrospective, have relied on adolescents and young adults as informants,
or both (Decker, Haase, & Bell, 2007; Novakovic et al., 1996; Zebrack & Chesler, 2002).
Although valuable descriptive information about the uncertainties inherent in the childhood
cancer experience has been provided, the results reflect cognitive and emotional insights gained
with maturity and therefore offer limited insight into the concurrent experiences or perspectives
of school-aged children. Stewart’s (2003) exploratory, qualitative study of uncertainty in
children undergoing cancer treatment partially addressed this knowledge gap by providing
compelling evidence that children as young as 9 years old recognize and respond to the
uncertainty inherent in cancer and treatment in ways that could affect their psychosocial
adjustment significantly.
Mishel’s (1988) Uncertainty in Illness theory has provided the framework for much of the
research into adults’ illness-related uncertainty, and has been employed in several studies with
children and adolescents with chronic illnesses (Hoff, Mullins, Chaney, Hartman, & Domek,
2002; Neville, 1998; Van Pelt, Mullins, Carpentier, & Wolfe-Christensen, 2006; White et al.,
2005). Uncertainty is described as the inability to determine the meaning of illness-related
events or to predict an outcome accurately, and can be influenced by many illness-specific and
individual factors (Mishel, 1988). Uncertainty can lead to psychological distress if coping
responses are insufficient to resolve the uncertainty or to manage the negative emotional
arousal if it cannot be resolved.
Central to Mishel’s Uncertainty in Illness theory is the proposition that uncertainty results when
a sufficient cognitive schema cannot be formed with which to interpret the meaning of illness-
related events (Mishel, 1988). Although this proposition has not been tested specifically in
children, there is evidence from the child psychology literature that by early school age,
children rely on cognitive schemata in the context of illness (Hergenrather & Rabinowitz,
1991), and that illness-related uncertainty may interfere with children’s capacity to form a
sufficient schema within which to interpret subsequent illness experiences (Bearison, 1991).
Further, Weisz (1990) has provided evidence that children experience heightened
psychological distress when they are unable to determine the cause and therefore the
controllability of events, a condition he refers to as contingency uncertainty. Appraisal of
uncertainty thereby could represent the type of cognitive process that Thompson and Gustafson
(1996) propose affects children’s psychological adjustment to illness more profoundly than
severity of the illness itself. Thus, the application of Mishel’s theory to the study of children’s
and adolescents’ uncertainty as a barrier to cognitive processing of illness-related experiences
should make an important contribution to understanding of children’s acute and long-term
responses to cancer.
Definitive studies will require a psychometrically sound measure of uncertainty in children
and adolescents with cancer. Mishel’s Uncertainty in Illness Scale (MUIS; Mishel, 1981),
developed and tested specifically in the context of adult illness, has been used in a limited
number of published studies of children and adolescents. Mullins and Hartman (1995) adapted
the Children’s Uncertainty in Illness Scale (CUIS) from the MUIS for use with children and
adolescents, and it has shown favorable reliability in multiple studies of chronic illness in
children and adolescents. However, the assumption that the meaning of the construct being
measured is the same as for adults has not been addressed specifically.
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An approach to instrument development with considerable promise for contributing to the
validity of self-report measures is using qualitative data to generate items indexing the construct
under study. The emphasis in qualitative research on intensively and comprehensively
understanding the dimensions, contexts, and relationships of a phenomenon echo the
requirements for validity in quantitative measurement (Mishel, 1998; Strauss & Corbin,
1994). The same interview data which are used to develop the conceptual structure and
dimensionality of the construct can provide the items which will index that construct, in the
language and context of those who have experienced the phenomenon (Fleury, 1993).
Qualitative research has been identified also as a particularly effective approach to representing
the unique perspective of children (Siegal, 1991).
The purpose of this presentation is to describe the development and initial psychometric
evaluation of an alternative measure of uncertainty derived from qualitative interviews with
children undergoing treatment for cancer. No clear theoretical or empirical guidance for
determining how the appraisal of uncertainty might change across the cognitive developmental
spectrum was found in the literature, so the goal was to develop an instrument that could be
used in both school-aged children and adolescents, such that future studies could address the
nature and experience of uncertainty more systematically as a developmental phenomenon.
Methods
Design
The instrument was constructed using qualitative data from an earlier study of uncertainty in
children undergoing cancer treatment (Stewart, 2003), and evaluated for content validity by
two panels of experts (one composed of children and adolescents with cancer, the other of
clinical nurse experts; Stewart, Lynn, & Mishel, 2005). Further psychometric evaluation was
then conducted with a sample of 72 children and adolescents undergoing cancer treatment.
Development of the Uncertainty Scale for Kids
Interview data from the Stewart’s (2003) qualitative study of uncertainty in children
undergoing cancer treatment were used to generate items for the Uncertainty Scale for Kids
(USK). Excerpts from the qualitative data that represented the three dimensions of children’s
uncertainty (not knowing, not being able to predict, and not being sure what things meant) were
isolated from the 11 interviews and translated into items, keeping the phrasing as close to the
child’s syntax and context as possible. Every passage that had been coded as representing one
of the three dimensions of uncertainty was used to generate a potential item. Eliminating
redundancy resulted in a set of 22 items that represented the content derived from the qualitative
data comprehensively. Using post hoc review revealed that 4 of the items corresponded to data
coded as “not knowing,” 12 to data coded as “not being able to predict,” and 6 to data coded
as “not being sure what things meant.” Using the simplified measure of gobbledygook SMOG
formula (McLaughlin, 1969), the reading level of the 22 items was determined to be third grade,
which was deemed the desirable reading level, since the target age range for the instrument
was 8 to 18 years. Since there are no published guidelines for a reasonable number of items on
a self-report scale intended for use with younger children, all 22 items were retained for
psychometric testing.
Two separate groups of experts were asked to review the 22 item stems for clarity,
comprehension, and relevance. The first consisted of six children with cancer, three adolescents
(aged 14–16 years) who had participated in Stewart’s (2003) qualitative study, and three
younger children (aged 8–11 years) who were undergoing cancer treatment. Each child met
with the first author individually to carry out the content validity review. The second group
consisted of four masters-prepared nurse clinicians with expertise in childhood cancer. Experts
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in each group were asked to rate each item for its relevance to the content domain, as well as
to suggest revisions that would improve its clarity and to identify content not indexed by the
existing set of scale items. Following Lynn’s (1986) quantification criteria for content validity,
items were retained if five of the six child experts and all four of the nurse experts agreed that
an item was relevant and acceptable. A detailed description of the procedures used to adapt
standard content validity review procedures for children has been previously published
(Stewart et al., 2005).
Once the final set of items was established, ordinal level scaling was added to provide children
with an array of choices to represent their responses. A 4-point response format prompts
respondents to indicate how often they felt unsure about each item, ranging from 1 (never) to
4 (always). This response format was chosen as a straightforward way for children and
adolescents to represent intensity of uncertainty as the frequency with which they experience
it.
Psychometric Evaluation
The USK, along with other study measures, was administered to participants aged 8 to 18 years
who were undergoing treatment for any form of cancer. Participants were at various stages of
treatment, including newly diagnosed, in remission, postrelapse, or awaiting or following stem
cell transplantation.
Item analyses were conducted using interitem and corrected item-total correlations. Internal
consistency was evaluated using Cronbach’s alpha for the total scale. A subset of 25 subjects
from a single institution (due to constraints on investigator resources) were asked to complete
the USK a second time to evaluate test-retest reliability; a 1-week test-retest interval was chosen
to minimize the degree of situational variability in uncertainty that can occur over relatively
short periods of time (Mishel, 1988).
Support for the validity of the USK was evaluated by determining the associations with time
since diagnosis, phase of treatment (continuous remission vs. active disease), intensity of
treatment (chemotherapy +/− surgery), level of cancer knowledge, and psychological distress
(anxiety and depressive symptoms). Based on Mishel’s Uncertainty in Illness theory, it was
anticipated that higher USK scores would be associated with less time since diagnosis, presence
of active disease (vs. remission status), more intensive treatment, less cancer knowledge, and
higher levels of anxiety and depressive symptoms.
Although the qualitative data used to generate the USK items suggested consistency between
children’s experiences with uncertainty and those indexed with the original MUIS (ambiguity,
unpredictability, lack of information, and inconsistency), the dimensionality of the USK was
not identified a priori, and therefore exploratory factor analysis (EFA) was used to examine
the factor structure. Given the relatively low subject-to-item ratio (approximately 3:1),
communalities (the proportion of item variance explained by the combined factors) were
examined in order to assess the generalizability of factor extractions (Hogarty, Hines, Kromrey,
Ferron, & Mumford, 2005). The quality of the final solution was evaluated with Kaiser/Meyer/
Olken (KMO) measure of sampling adequacy (considered acceptable if > 0.75–.80), Bartlett’s
test of sphericity, the amount of variance explained, the relationship of items to factors (number
of items per factor, item loadings ≥ 0.40, internal consistency of factors), and the theoretical
meaningfulness of the resulting factors.
Procedures
Data were collected at four pediatric cancer centers affiliated with the Children’s Oncology
Group (COG), a cooperative study group representing most of the institutions across the United
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States participating in cancer clinical trials research with children and adolescents. Approval
for the study was obtained from each participating site’s Institutional Review Board prior to
identification of subjects and initiation of data collection. Potential subjects were excluded if
they did not speak English, if they could not read at the second-grade level, or if in the opinion
of their treatment team they were too ill to participate. Members of the treatment teams at the
respective facilities were asked to identify and approach all eligible subjects; neither
demographic data nor reasons for ineligibility were obtained for those deemed ineligible by
the treatment team. Once a member of the clinical staff had determined the family’s willingness
to speak with the investigator, the investigator explained the study in detail and obtained
consent from the parent and assent from the child, who was assured that participation in the
study was not required even if the child’s parent had given consent. The treatment team was
not informed of the family’s decision whether or not to participate.
Data collection took place at a location most convenient for the family. Overwhelmingly,
families stated a preference to meet with the investigator at the treatment facility in order to
minimize intrusion of illness-related issues into their daily lives; one parent asked the
investigator to travel to the family’s home, and the remaining participants completed study
instruments in the inpatient or outpatient setting where they were receiving treatment.
Questionnaires were read to all children aged 10 years and younger and to any participant who
preferred to have the instruments read to them. When instruments were read out loud, the
investigator met with the participant privately or asked express permission to conduct the data
collection interview in the presence of the parent. Participants who completed the instruments
independently were often in the same room as their parent, but no discussion of responses took
place in front of the parent to ensure their responses remained confidential. Individual responses
were not shared with parents or treatment team members. All consent forms and raw data were
kept in a locked file within the primary investigator’s home, and no identifying information
was entered into the electronic data files used for analysis and reporting of findings.
The test-retest participants were given a copy of the USK to take home along with a stamped,
self-addressed envelope for return to the investigator. The participants were asked not to
attempt to remember their original answers but to respond to the questionnaires based on how
they were feeling that day. Two children (aged 9 and 10 years) in the subset had the measures
read to them by the investigator at initial data collection; the investigator reviewed the retest
instrument with these children to determine that they were capable of completing the instrument
themselves the second time. The investigator called participants on the day the retest was
scheduled to remind them to complete and return the scales.
Additional Measures
Demographic and treatment characteristics—Parents provided the following
information: child’s date of birth, ethnicity, type and date of cancer diagnosis, and cancer
treatment previously or currently received (chemotherapy, radiation, surgery to debulk or
remove tumor tissue, hematopoetic stem cell transplant [HSCT], other). As indices of treatment
intensity, children were classified as receiving chemotherapy alone or in combination with
radiation, surgery, or both, as well as HSCT (yes/no).
Cancer knowledge—This investigator-developed scale was created for use in the current
study, based on published cancer educational materials designed for children, and consisted of
12 true or false statements representing general information about childhood cancer and
common side effects to treatment (e.g., hair loss, risk of infection, radioactivity). Because the
intended sample was heterogeneous in type of cancer and treatments received, items were
limited to general content; that is, not specific to any particular diagnosis or treatment modality.
Missing responses were scored as incorrect. The scale score was constructed by summing the
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number of correct answers for each subject. The scale was evaluated for content validity by
the same four clinical experts who evaluated the USK; the experts agreed that each of the items
were relevant, with three items undergoing minor revision to improve clarity. In this study
sample, the KR-20 of 0.44, likely due at least in part to the high proportion of correct responses
(> .60 for 11 of 12 items), indicates poor internal consistency. Item discrimination indices
ranged from 0.11 to 0.52, with point biserial values for 5 of 12 items achieving significance.
Cancer knowledge scores were positively correlated with age (r = .36, p < .01), indicating that
older children had more cancer-specific knowledge.
Depressive symptoms—The Children’s Depression Inventory (CDI; Kovacs, 1985) is a
27-item self-report scale that is used to elicit children’s depressive symptomatology for the
previous 2 weeks; it has first-grade readability. Each item has three response options, graded
from 0 to 2 in the direction of increasing depressive symptomatology. Total scores are summed
across items and range from 0 to 54. The CDI’s reliability has been demonstrated by internal
consistency coefficients ranging from .87 to .94 (Kovacs, 1985; Saylor, Finch, Spirito, &
Bennett, 1984), including alpha = .89 in a sample of children with cancer (Phipps & Srivastava,
1997). The CDI has accumulated considerable evidence for reliability and construct, predictive,
and discriminant validity in non-ill and chronically ill children (Carey, Faulstich, Gresham,
Ruggiero, & Enyart, 1987; Wood et al., 2007; White et al., 2005). The Cronbach’s alpha for
the current sample was .80.
Anxiety—The Revised Children’s Manifest Anxiety Scale (RCMAS; Reynolds & Richmond,
1978) is a 28-item, self-report measure of children’s anxiety and worry, and includes an
additional 9 items to index social desirability response bias. Dichotomous responses are scored
as 1 for yes or true for you and 0 for no or not true for you. Total scale scores are summed
across each subscale and range from 0 to 28 for anxiety or worry and 0 to 9 for social
desirability, with higher scores indicating higher levels of anxiety or worry or social desirability
bias. Anxiety or worry and social desirability scores were correlated only modestly (r = .15,
p < .01) in the original field test with 329 school children grades 1 through 12 (Reynolds &
Richmond, 1978). Reliability for the anxiety or worry scale is supported by KR-20 estimates
ranging from .83 to .85, and stability by 3-week test-retest correlation of .98 (Pela & Reynolds,
1982). The scale discriminates between anxious and nonanxious samples (Perrin & Last,
1992; Seligman, Ollendick, Langley, & Baldacci, 2004), strongly correlates with children’s
scores on the trait subscale of the State-Trait Anxiety Scale for Children (Reynolds, 1980), and
has demonstrated adequate reliability and validity in samples of children with acute and chronic
illness (DeMaso et al., 2000; Loney, Wirrell, Sherman, & Hamiwka, 2008). The KR-20
estimate of reliability for the current sample was 0.87.
Sample
Seventy-two children and adolescents undergoing cancer treatment constituted the sample for
psychometric evaluation (Table 1). The mean age was 13 years (SD = 2.9 yrs). The sample
was predominantly Caucasian (72%) and male (58%). Most of the participants had been
diagnosed with leukemia or lymphoma (67%) and were in remission (68%). By far the most
common treatment was chemotherapy (94%), with 42% also undergoing radiation, surgery, or
both, and 11% having HSCT. Other than the underrepresentation of central nervous system
(CNS) tumors, attributed to recruitment from pediatric oncology practices that typically see
patients with CNS tumors only when they are treated with chemotherapy, the sample
characteristics are generally representative of the population of children with cancer treated in
the Southeastern United States. The mean time since diagnosis (18.6 months, SD = 24.2) was
skewed by two participants with long illness durations, and thus the median of 11.9 months is
more representative of central tendency. Because of this major departure from the normal
distribution, the natural logarithm of the months since diagnosis was calculated to create the
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variable time since diagnosis. This new variable more closely approximated a normal
distribution with a mean of 2.4 (SD = 1.1).
Ten eligible children and adolescents (6 boys and 4 girls, mean age = 12.5 years, all Caucasian)
declined participation in the study and 3 mothers (all with Caucasian girls, mean age = 10
years) declined their child’s participation in the study, yielding a refusal rate of 15.3%. One
15-year-old said she had no uncertainty because of her strong faith in God; the other 9 who
refused said they were simply not interested. One mother was concerned that introducing the
USK would raise the issue of potential bad outcomes for her child; one mother was generally
skeptical of psychosocial research; and one mother expressed that her family was too
overwhelmed with the diagnosis to participate at that time.
Results
Content Validity
For 20 of the 22 original items, at least five of the six child experts agreed that the item was
good or okay. These items were retained as written or with minor revisions based on the
children’s comments. The two items that did not meet the standard were reworded substantially
after addressing children’s comments about why these items were irrelevant or how they could
be improved. All four clinical experts agreed that each of the 22 items was relevant. None of
the child or clinical experts identified additional relevant content. The 22 items incorporating
the children’s input constituted the set of items subjected to further psychometric evaluation.
Item Analyses
Item means, standard deviations, and corrected item-total correlations are presented in Table
2, ranked by item means. The majority of interitem correlations ranged between 0.30 and 0.70,
with the exception of one item (How I got cancer) that showed correlations below 0.30 with
18 of the remaining 21 items. Similarly, this item’s corrected item-total correlation (0.29) was
the only one that was below 0.30.
Reliability
The USK demonstrated strong internal consistency with Cronbach’s alpha = 0.94. The 1-week
test-retest reliability was moderately strong (r = .64, p = .005).
Validity
As predicted, USK scores were correlated moderately with anxiety (r = .56, p < .001) and
depressive symptoms (r = .59, p < .001; Table 3). The USK was not correlated significantly
with time since diagnosis or with cancer knowledge, although the valences were in the expected
direction. Post hoc exploratory analysis demonstrated that cancer knowledge was correlated
significantly with age (r = .36, p < .001); when age was controlled, the correlation of USK
scores with cancer knowledge remained weak but achieved significance (r = −.27, p = .02).
The USK scores showed no correlation to stage of treatment (remission vs. other stage of
disease). Participants who were treated with chemotherapy alone had lower USK scores (mean
= 44.4, SD = 14.2) than those who had also undergone surgery, radiation, or both (M = 55.8,
SD = 15.0, t63 = 3.06, p = .003). A similar but nonsignificant trend was seen in children and
adolescents who underwent HSCT (M = 59.0, SD = 14.4) versus those who did not (M = 48.5,
SD = 15.6, t70 = 1.80, p = .08).
Dimensionality
Bartlett’s Test of Sphericity was significant (approximate χ2 = 977.06, df = 231, p < .001) and
the Kaiser-Meyer-Olkin Measure of Sampling Adequacy (KMO) was robust at 0.893,
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providing evidence for an ample number of significant correlations among items to justify
proceeding with factor analysis. Principal Axis Factoring (PAF) was performed initially with
an orthogonal (Varimax) rotation, which converged in 3 iterations and yielded 4 factors with
Eigenvalues > 1.0 that explained 56.6% of the variance. However, the scree plot demonstrated
a clear elbow between the second and third factors. The first factor contained 12 items with
factor loading values ranging from .47 to .79, and the second factor contained 7 items with
factor loadings from .43 to .66. The third and fourth factors each had only 1 item, and one item
did not load on any of the factors. Therefore, PAF with Varimax rotation was repeated
extracting only two factors, which accounted for 50.4% of the variance. Thirteen items loaded
on the first factor, eight items on the second factor, and one item (How I got cancer) loaded
on neither factor. There was mild cross-loading between the two factors. The summed scores
for the items loading on each of the two factors were correlated strongly (r = .72) and, therefore,
PAF was repeated extracting two factors using oblique (Oblimin) rotation. The rotated solution
was essentially the same, except that one item (What exactly is making me feel sick) which had
loaded previously on both factors now loaded weakly on the first factor. Estimated item
communalities, factor loadings (pattern matrix coefficients are reported; structure matrix
coefficients are available upon request), and item-factor correlations for this obliquely rotated
solution are presented in Table 4.
Many of the 12 items that loaded on the first factor related to not being able to tell how serious
the illness is overall or at any given moment, represented by items such as Whether or not I’m
doing okay and If I’ll miss out on fun things because of my cancer. The average interitem
correlation of .60 (range .46–.72) and Cronbach’s alpha = 0.95 indicated strong internal
consistency and possible item redundancy. The 8 items that loaded on the second factor related
more to not knowing exactly what will happen day to day, represented by items such as If
treatments will happen when they are scheduled and What side effects I’m going to have. The
average interitem correlation of .39 (range .24 to .65) and Cronbach’s alpha = .84 indicated
strong internal consistency for the second factor.
Discussion
The USK, developed from the perspective of children and adolescents with cancer and shaped
by the contributions of child content validity experts, performed well in the initial application,
demonstrating strong reliability and preliminary evidence for validity. The strongest evidence
for construct validity is provided by the robust correlation of USK scores with both anxiety
and depression, consistent with the theoretical premise that in the absence of effective
management strategies, uncertainty can lead to psychological distress. The association with
situational factors that may inhibit the development of an adequate cognitive schema and
thereby increase uncertainty was less consistent. The higher USK scores for children and
adolescents undergoing more complex treatment regimens provides preliminary support for
discriminant validity, and the weak association between cancer knowledge and USK scores
when age is controlled is additional, albeit modest, evidence for construct validity. Statistical
problems with the measures for both time since diagnosis (significantly skewed) and cancer
knowledge (low internal consistency), as well as crude indices of treatment intensity and phase
of treatment, may have compromised the detection of additional relevant associations. Further
studies to evaluate the validity of the USK are warranted. It would be particularly useful to
compare scores on the USK, conceptualized as an illness-specific measure of uncertainty, with
the MUIS (Mishel, 1981) or the CUIS (Mullins & Hartman, 1995), which are used to measure
uncertainty in nonspecific illness contexts. Such a comparison would provide additional
information about the USK’s validity as well as insight into the contexts most appropriate for
using the various instruments.
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The EFA suggests that two related dimensions may contribute to children’s and adolescents’
uncertainty during cancer treatment. Not being able to determine the seriousness of the illness
is consistent with Mishel’s characterization of ambiguity as the inability to determine the
meaning of illness-related events, whereas not knowing exactly what will happen when reflects
the unpredictability of the treatment trajectory. The single item indexing etiologic uncertainty--
not knowing how one got cancer--demonstrated less quantitative evidence for indexing the
central construct. However, 63 of the 72 participants indicated that they felt unsure about it at
least some of the time, with 20 indicating they felt unsure about it all the time. Therefore, all
22 items should be retained for further psychometric evaluation. If the factor solution
demonstrates stability and the Cronbach’s alpha remains high as an indication of possible item
redundancy, the total number of items could be reduced to limit subject burden.
The primary limitation of this study was the relatively small sample size, although the moderate
to strong item communalities, particularly in light of the limited number of extracted factors
and probable overidentification of the first factor, as well as the robust KMO measure, argue
for stability of the factor solution (Hogarty et al., 2005). In addition, while reflecting the typical
population of children with cancer seen in United States centers, the sample demonstrated
limited racial and ethnic variability. The previously detailed measurement problems as well as
the low subject-to-item ratio also limited the evaluation of validity. A second field test with a
larger sample of children and adolescents with cancer would provide additional information
about the validity of the USK and contribute to a better understanding of the dimensionality
of children’s and adolescents’ uncertainty.
Research into the experiences of families facing childhood cancer have relied heavily on the
perspectives of parents or adolescents looking back on their time in treatment, and as such have
failed to capture the true complexity of influences on individual and family functioning. Despite
the characterization in the literature of childhood cancer as inherently uncertain, few
researchers have investigated uncertainty specifically from children’s perspectives, and
therefore the impact of uncertainty on children’s adjustment has been largely unexamined.
Given that the USK shows promise as a psychometrically sound instrument to measure
uncertainty in children and adolescents, the previous work on uncertainty in the context of
childhood cancer can be expanded to incorporate the perspectives of children as young as 8
years into an understanding of how living with such an illness affects families.
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Table 1
Sample Characteristics
Mean Standard Deviation Median Range
Age in years 13.0 2.9 13 8 – 18
Grade in school 8 2.7 8 1–12






 African American 15 20.8
 Asian American 2 2.8
 Caucasian 52 72.2
 Hispanic 2 2.8
 Native American 1 1.4
Diagnoses
 Leukemia/Lymphoma 48 66.7
 Solid tumor 17 23.6










Notes. HSCT = hematopoetic stem cell transplantation













Stewart et al. Page 13
Table 2
Item Means, Standard Deviations, and Corrected Item-Total Correlations
Item Mean Standard Deviation Corrected Item- Total Correlation
If I’ll miss out on fun things because of my cancer 2.77 1.2 .70
Why cancer happened to me 2.75 1.1 .70
When I will be through with all of this 2.66 1.2 .73
If everything will go all right 2.54 1.2 .80
How I got cancer 2.53 1.0 .29
How things are going to come out 2.53 1.1 .73
What’s going to happen next 2.51 1.1 .76
How bad the treatment will make me feel 2.44 1.1 .66
Which side effects I’m going to have 2.37 1.0 .62
Whether or not I’m doing okay 2.32 1.0 .73
If things will go according to the plan 2.30 1.1 .78
If something bad might show up in my tests 2.30 1.0 .77
What exactly is making me feel sick 2.28 1.1 .54
If I’m going to get better or not 2.24 1.2 .70
When I feel sick, is it serious or no big deal 2.15 1.0 .70
How much treatment I have to get 2.08 .9 .47
What is going on with me 2.07 1.0 .76
If there will be any surprises when I get a treatment 2.03 .9 .54
If my cancer is getting worse 1.99 1.0 .71
If treatments will happen when they are scheduled 1.86 1.0 .53
Whether I’m being told the truth 1.70 1.0 .42
Why I have to get treatment 1.65 1.0 .39
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